Predilife S.A (ALPRE) | Financial Analysis & Statements
Predilife S.A. | Small-cap | Healthcare
Predilife S.A. | Small-cap | Healthcare
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
618.1K
Gross Profit
604.2K
97.76%
Operating Income
-4.0M
-645.02%
Net Income
198.6M
32,137.35%
Balance Sheet Metrics
Total Assets
2.4M
Total Liabilities
6.7M
Shareholders Equity
-4.3M
Cash Flow Metrics
Operating Cash Flow
-4.3M
Free Cash Flow
-3.7M
Revenue & Profitability Trend
Predilife S.A Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 618.1K | 317.8K | 288.7K | 142.7K | 282.2K |
| Cost of Goods Sold | 13.8K | 10.9K | 36.2K | 49.3K | 38.6K |
| Gross Profit | 604.2K | 306.9K | 252.5K | 93.4K | 243.6K |
| Operating Expenses | 2.2M | 2.1M | 1.9M | 2.9M | 1.1M |
| Operating Income | -4.0M | -3.8M | -3.5M | -3.5M | -2.5M |
| Pre-tax Income | -4.8M | -4.5M | -3.8M | -3.7M | -2.5M |
| Income Tax | -342.4K | -232.1K | -256.1K | -294.8K | -290.3K |
| Net Income | 198.6M | -4.2M | -3.6M | -3.4M | -2.3M |
| EPS (Diluted) | - | -€1.14 | -€1.00 | -€0.93 | -€0.64 |
Income Statement Trend
Predilife S.A Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 2.0M | 3.3M | 4.6M | 3.7M | 3.8M |
| Non-Current Assets | 458.1K | 1.1M | 4.6M | 270.7K | 288.4K |
| Total Assets | 2.4M | 4.4M | 9.2M | 4.0M | 4.1M |
| Liabilities | |||||
| Current Liabilities | 1.7M | 710.1K | 1.2M | 400.3K | 637.7K |
| Non-Current Liabilities | 5.0M | 7.6M | 7.0M | 5.1M | 2.7M |
| Total Liabilities | 6.7M | 8.3M | 8.2M | 5.5M | 3.4M |
| Equity | |||||
| Total Shareholders Equity | -4.3M | -3.9M | 957.0K | -1.6M | 721.7K |
Balance Sheet Composition
Predilife S.A Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -4.3M | -4.2M | -3.7M | -3.4M | -2.3M |
| Operating Cash Flow | -4.3M | -4.2M | -3.7M | -3.4M | -2.3M |
| Investing Activities | |||||
| Capital Expenditures | -5.4K | -42.4K | 7.7K | -3.4K | -15.7K |
| Investing Cash Flow | -706.4K | -42.4K | 7.7K | -10.6K | -33.7K |
| Financing Activities | |||||
| Dividends Paid | - | - | - | - | - |
| Financing Cash Flow | 2.2M | 3.0M | 4.0M | 3.5M | 5.0M |
| Free Cash Flow | -3.7M | -4.3M | -3.1M | -3.8M | -2.1M |
Cash Flow Trend
Predilife S.A Key Financial Ratios
Valuation Ratios
Forward P/E
-2.41
Price to Sales
28.12
Profitability Ratios
Profit Margin
97.76%
Operating Margin
-558.18%
Return on Equity
-4,653.75%
Return on Assets
-73.10%
Financial Health
Current Ratio
1.38
Debt to Equity
-1.16
Beta
0.38
Per Share Data
EPS (TTM)
-€1.19
Book Value per Share
-€3.50
Revenue per Share
€0.13
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| alpre | 13.9M | - | - | -4,653.75% | 97.76% | -1.16 |
| Lumibird S.A | 353.3M | 61.73 | 1.78 | 2.91% | 2.71% | 81.34 |
| Eurofins Cerep SAS | 103.9M | 14.33 | - | 10.49% | 17.67% | 0.46 |
| Klea Holding | 53.9M | 17.87 | 1.92 | 5.35% | 8.14% | 21.13 |
| bioMérieux S.A | 14.2B | 32.96 | 3.37 | 10.68% | 10.86% | 11.65 |
| Eurofins Scientific | 10.6B | 28.48 | 2.56 | 7.71% | 5.85% | 67.05 |
Financial data is updated regularly. All figures are in the company's reporting currency.